Correlation Between Lyra Therapeutics and Exscientia
Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and Exscientia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and Exscientia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyra Therapeutics and Exscientia Ltd ADR, you can compare the effects of market volatilities on Lyra Therapeutics and Exscientia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of Exscientia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and Exscientia.
Diversification Opportunities for Lyra Therapeutics and Exscientia
-0.16 | Correlation Coefficient |
Good diversification
The 3 months correlation between Lyra and Exscientia is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and Exscientia Ltd ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exscientia ADR and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with Exscientia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exscientia ADR has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and Exscientia go up and down completely randomly.
Pair Corralation between Lyra Therapeutics and Exscientia
Given the investment horizon of 90 days Lyra Therapeutics is expected to under-perform the Exscientia. In addition to that, Lyra Therapeutics is 1.2 times more volatile than Exscientia Ltd ADR. It trades about -0.02 of its total potential returns per unit of risk. Exscientia Ltd ADR is currently generating about 0.01 per unit of volatility. If you would invest 648.00 in Exscientia Ltd ADR on November 6, 2024 and sell it today you would lose (164.00) from holding Exscientia Ltd ADR or give up 25.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 90.04% |
| Values | Daily Returns |
Lyra Therapeutics vs. Exscientia Ltd ADR
Performance |
| Timeline |
| Lyra Therapeutics |
| Exscientia ADR |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Lyra Therapeutics and Exscientia Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lyra Therapeutics and Exscientia
The main advantage of trading using opposite Lyra Therapeutics and Exscientia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, Exscientia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exscientia will offset losses from the drop in Exscientia's long position.| Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
| Exscientia vs. Zura Bio Limited | Exscientia vs. Elevation Oncology | Exscientia vs. Recursion Pharmaceuticals | Exscientia vs. Atea Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |